News Headlines Article

Health Care Digest: Gilead’s big plan for rheumatoid arthritis, Gladstone’s new heart chief, Chan Zuckerberg’s cell atlas and more
San Francisco Business Times

One of brain research’s longtime bugaboos, especially in trying to find treatments for mental illnesses, Alzheimer’s disease and the like, is the ability to figure out just how drugs are behaving in and around our gray matter.

Kunal Ghosh thinks his company, Inscopix Inc., has an answer: The Palo Alto company’s miniature microscope creates a real-time map to see how brain activity changes among healthy and unhealthy tissue. At least in mice.